Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts
Medtronic
Mallinckrodt
Dow

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Facta Farma Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for FACTA FARMA, and what generic and branded alternatives to FACTA FARMA drugs are available?

FACTA FARMA has eight approved drugs.



Summary for Facta Farma
US Patents:0
Tradenames:4
Ingredients:4
NDAs:8

Drugs and US Patents for Facta Farma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Facta Farma CEFACLOR cefaclor FOR SUSPENSION;ORAL 062206-004 Apr 20, 1988 DISCN No No   Start Trial   Start Trial
Facta Farma CEPHALEXIN cephalexin CAPSULE;ORAL 062118-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Facta Farma CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065268-001 Feb 28, 2007 DISCN No No   Start Trial   Start Trial
Facta Farma CEFACLOR cefaclor FOR SUSPENSION;ORAL 062206-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Express Scripts
Colorcon
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.